Equity (Details) - USD ($)	3 Months Ended					9 Months Ended
	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Equity (Details) [Line Items]
Common Stock, Shares Authorized	75,000,000					75,000,000		75,000,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)	$ 0.0001					$ 0.0001		$ 0.0001
Stock Issued During Period, Shares, New Issues	500,000	700,000	480,000	480,000
Proceeds from Issuance of Common Stock (in Dollars)	$ 125,000	$ 175,000	$ 120,000	$ 120,000		$ 300,000	$ 240,000
Stock Issued During Period, Shares, Other					34,371,100
Stock Issued During Period, Value, Other (in Dollars)					$ (1,091)
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs (in Dollars)					4,528
Common Stock, Shares, Outstanding	42,096,221					42,096,221		40,896,221
Common Stock, Shares, Issued	42,096,221					42,096,221		40,896,221
Preferred Stock, Shares Authorized								5,000,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)	$ 0.0001					$ 0.0001		$ 0.0001
Preferred Stock, Conversion Basis						Each share of the Series A is convertible into three shares of the Company’s common stock at the holder's election, subject to a 4.99% beneficial ownership limitation which may be increased to 9.99% upon 61 days’ notice
Preferred Stock, Shares Outstanding	140,000					140,000		140,000
Series A Preferred Stock [Member]
Equity (Details) [Line Items]
Preferred Stock, Shares Authorized								1,000,000
Best 365 Labs Inc. [Member]
Equity (Details) [Line Items]
Stock Issued During Period, Value, Other (in Dollars)					$ 3,437